v3.25.2
Equity Transactions (Tables)
9 Months Ended 12 Months Ended
Mar. 31, 2025
Jun. 30, 2024
Equity [Abstract]    
Schedule of summarizes the activity relating to the Company’s stock options
                    
   Options   Weighted-
Average
Exercise
Price
   Weighted
Remaining
Average
Contractual
Term
   Aggregate
Intrinsic
Value
 
Outstanding at June 30, 2024   518,076   $54.11    6.1   $- 
Options Granted   490,261    2.40    7.1    - 
Options Expired   (38,806)   62.48    -    - 
Options Canceled   (82,402)   7.87    -    - 
Outstanding at March 31, 2025   887,129   $29.46    6.2   $- 
Exercisable at March 31, 2025   448,470   $44.50    5.1   $- 
                    
   Options   Weighted-Average Exercise Price   Weighted Remaining Average Contractual Term   Aggregate Intrinsic Value 
Outstanding at June 30, 2022   339,876   $74.20    5.5   $- 
Granted   71,467    59.00    8.6    38,610 
Options Expired   (1,000)   286.90    -    - 
Options Canceled   (4,967)   77.40           
Options Exercised   (10,090)   81.20    -    - 
Outstanding at June 30, 2023   395,286    71.00    6.3    1,067,966 
Granted   155,242    11.70    9.8    - 
Options Expired   (640)   46.09    -    - 
Options Canceled   (31,812)   57.19    -    - 
Outstanding at June 30, 2024   518,076   $54.11    6.1   $- 
Exercisable at June 30, 2024   296,934   $66.65    4.9   $- 
Schedule of assumptions used
     
  March 31, 2025   March 31, 2024
Expected life of options (in years) 4   5
Expected volatility 93.44%   87.11%
Risk free interest rate 4.34%   4.80%
Dividend Yield 0%   0%
     
  June 30, 2024   June 30, 2023
Expected life of options (in years) 6   6
Expected volatility 86.28%   81.65%
Risk free interest rate 4.40%   3.82%
Dividend Yield 0%   0%
Schedule of unvested of restricted stock units
          
   Number of Shares   Weighted
Average
Grant Date
Fair Value
Per Share
 
         
Unvested at June 30, 2024   40,291   $44.59 
Issued   171,900    2.56 
Vested   (74,643)   11.67 
Canceled   (28,509)   6.67 
Unvested at March 31, 2025   109,039   $10.81 
          
   Number of Shares   Weighted Average Grant Date Fair Value Per Share 
Unvested at June 30, 2022   12,452   $16.90 
Granted   68,711    58.87 
Vested   (21,518)   52.70 
Unvested at June 30, 2023   59,646   $52.40 
Issued   104,070    9.16 
Vested   (122,395)   16.94 
Canceled   (1,030)   61.20 
Unvested at June 30, 2024   40,291   $44.59 
Summary of warrants activity
                    
   Number of Shares   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Life (Years)
   Aggregate
Intrinsic
Value
 
Outstanding and exercisable at June 30, 2024   1,932,029   $14.03    4.0   $- 
Granted   10,181,640    1.65    4.8    - 
Exercised   (2,502,967)   1.53    -    - 
Expired   (10,138)   21.94    -    - 
Outstanding and exercisable at March 31, 2025   9,600,564   $3.50    4.3   $- 
                    
   Number of Shares   Weighted Average Exercise Price   Weighted Average Remaining Life (Years)   Aggregate Intrinsic Value 
Outstanding and exercisable at June 30, 2022   51,037   $61.70    3.8   $- 
Granted   727,273    18.20    5.0    - 
Expired   (482)   750.00    -    - 
Exercised   (800)   22.50    -    - 
Outstanding and exercisable at June 30, 2023   777,029    20.60    4.0    18,318,954 
Granted   1,755,000    13.14    5.0    - 
Exercised   (600,000)   10.00    -    - 
Outstanding and exercisable at June 30, 2024   1,932,029   $14.03    4.0   $- 
Schedule of warrants outstanding
     
   Number of Warrants 
     
Expiring June 30, 2025   - 
2026   3,518 
2027   36,100 
2028   727,273 
2029   1,155,000 
2030   7,678,673 
Total outstanding warrants   9,600,564